Combined G-CSF treatment with dipeptidyl peptidase-IV (DPP-IV) inhibition limiting the proteolytic degradation of SDF-1 plus cell cycle activation in cardiomyocytes even enhanced cardiac regeneration after MI [5]. The gene discussed is DPP4; the disease is myocardial infarction.